Filing Details
- Accession Number:
- 0000950117-10-001475
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-21 12:31:15
- Reporting Period:
- 2009-01-21
- Filing Date:
- 2010-12-21
- Accepted Time:
- 2010-12-21 12:31:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1420720 | Ibio Inc. | IBPM.OB | Pharmaceutical Preparations (2834) | 262797813 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1102948 | Carl Desantis | 3299 Nw 2Nd Avenue Boca Raton FL 33431 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2009-01-21 | 35,778 | $0.29 | 5,551,419 | No | 4 | P | Indirect | FN |
Common Stock | Acquisiton | 2009-01-21 | 28,000 | $0.29 | 5,551,419 | No | 4 | P | Indirect | FN |
Common Stock | Acquisiton | 2010-10-27 | 250,000 | $2.00 | 5,551,419 | No | 4 | P | Indirect | FN |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | FN |
No | 4 | P | Indirect | FN |
No | 4 | P | Indirect | FN |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2010-10-27 | 250,000 | $0.00 | 250,000 | $2.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
250,000 | 2010-10-27 | 2015-10-27 | No | 4 | P | Indirect |
Footnotes
- Includes (i) 6,125 shares of common stock owned directly by the reporting person, (ii) 1,266,706 shares of common stock held by Integrated BioPharma, Inc., of which the reporting person is a controlling person, (iii) 1,719,393 shares of common stock held by CD Financial, LLC, (iv) 250,000 shares of common stock issuable upon exercise of a warrant held by CD Financial, LLC, and (v) 2,245,417 shares of common stock held by the DeSantis Revocable Trust.
- Warrant issued together with shares of common stock sold at a purchase price of $2.00 per share.